Article
Laminin 332 expression and prognosis in breast cancer.
Human pathology - 1 Dec 2018
Carpenter Philip M, Ziogas Argyrios, Markham Emma M, Cantillep Alegria S, Yan Rui, Anton-Culver Hoda
Abstract excerpt
The purpose of this study was to determine the distribution of and potential significance of laminin 332 (LM332) in breast cancer. Specimens from a population-based cohort (N = 297) from 1994 to 1995 were stained for estrogen receptor (ER), progesterone receptor (PgR), HER2 and the LM332 β3 chain. Seventy-five tumors were LM332-positive and 222 were negative. LM332 β3 stained 16.0% of ER and/or PgR-positive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
